News Author: Christopher Palmer Publish date: June 18, 2020
Ultrasound offers several benefits over other imaging modalities, too.
News Author: Christopher Palmer Publish date: June 18, 2020
Canakinumab (Ilaris) had previously been approved for the juvenile-onset form of Still’s disease, also known as systemic juvenile idiopathic arthri...
News Author: Christopher Palmer Publish date: June 1, 2020
This is the first IL-17A antagonist to receive FDA approval for this indication.
News Author: Christopher Palmer Publish date: May 22, 2020
ID specialists are also listed as among the highest in time spent on paperwork per week and among the lowest in f...
News Author: Christopher Palmer Publish date: May 21, 2020
This is the first known case of subacute thyroiditis being associated with SARS-CoV-2 infection, according to the...
News Author: Christopher Palmer Publish date: May 21, 2020
Among ob.gyns., 38% report that gratitude and relationships with patients is the most rewarding part of their job.
News Author: Christopher Palmer Publish date: May 5, 2020
More than half of the shampoo products labeled hypoallergenic contained cocamidopropyl betaine.
News Author: Christopher Palmer Publish date: April 15, 2020
Rates were significantly higher in rural areas than urban ones in 2018.
News Author: Christopher Palmer Publish date: April 8, 2020
The FDA had recently released guidance on steps companies need to take to submit complete applications for products like this.
News Author: Christopher Palmer Publish date: April 2, 2020
The new treatment is made using milk from transgenic rabbits.
News Author: Christopher Palmer Publish date: March 30, 2020
A phase 3 study showed a safety profile similar in both pediatric and adult patients, albeit with greater rates of conjunctivitis, influenza, and u...
News Author: Christopher Palmer Publish date: March 26, 2020
Despite increased HIV risk, many transgender youth felt discouraged from seeking help and info because providers ...
News Author: Christopher Palmer Publish date: March 26, 2020
It is the only approved sphingosine-1-phosphate receptor modulator with no requirement for genetic testing or label-based first-dose observation.
News Author: Christopher Palmer Publish date: March 20, 2020
During the COVID-19 pandemic, “it is especially important” for clinicians to ensure that individuals with OUD continue to receive evidence-based ca...
News Author: Christopher Palmer Publish date: March 8, 2020
Tests at age 6 years provided the best diagnostic accuracy for finding risk for cognitive impairment at age 12 years.
